CortControl, LLC

CortControl, LLC is a visionary intellectual property and medical foods research corporation. Our development of innovative, patented medical food compound formulas for the treatment of chronic diseases offers promising advances in the early stage emerging market of medical foods, a recently defined formal FDA category.
Medical foods must conform to FDA requirements and are not pharmaceuticals or health food stores nutraceuticals. Vendors are required to conduct SSA (Significant Scientific Agreement) studies to validate any claims regarding product’s health benefits.

CortControl is currently undertaking SSA trial studies for FDA approval of our Glutrasol product line, a highly promising new treatment protocol that improves and reduces stress and cortisol levels, improving the immune system. Safeguarded by patent, Glutrasol treatments are available for licensing to medical food manufacturers and distributors for prescribed treatment by professional medical personnel.
First phase testing is focused on Glutrosal IF as a prescription treatment for infertility, the first of seven indications CortControl plans to develop which will include:
• infertility
• vaccine enhancement
• breast cancer
• heart disease
• diabetes
• depression
• sleep disorder
CortControl is committed to values of safety, integrity, transparency, accountability and quality in our research and development of medical food compounds as exciting new treatments for a healthy immune system.